Africa: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Updates On The Recent Activities And Other Developments In National Agency For Food And Drug Administration & Control (NAFDAC)
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning over a suspected counterfeit version of the asthma medication Pulmicort® (Budesonide), detected in the Nigerian market and marketed under the name “Ulmicort 0.5mg/ml Inhalation Suspension”. In Public Alert No. 037/2026, the Agency cautioned that the suspected fake medicine may lack the correct ingredient or contain harmful substances and urged healthcare professionals and the public to report any suspected counterfeit medicines to the nearest NAFDAC office.
Nigeria Healthcare
SA
S.P.A. Ajibade & Co.
Article
Regulatory Pulse - July 2026
The Federal Government has launched the National Guidelines for Public Procurement of Food and Related Services, positioning government procurement as a public-health intervention to promote healthier diets, improved nutrition and prevention of non-communicable diseases. The Guidelines are intended to influence food served and purchased across public institutions, including hospitals, schools and government establishments
Nigeria Healthcare
HE
Health Ethics and Law Consulting
Article
Health And Pharmaceutical Sector Round-Up For Q2 Of 2026: Key Developments And Outlook For Q3 2026
Q2 2026 marked a pivotal period for Nigeria's health and pharmaceutical sector, as the government shifted from broad policy statements to concrete implementation measures. What do the new National Malaria Strategic Plan, emergency medical response initiatives, and digital pharmacy regulations mean for healthcare operators, investors, and service providers navigating this evolving regulatory landscape?
Nigeria Healthcare
SB
Stren & Blan Partners
See more

Healthcare

Article
CJEU Ruling Clarifies Scope Of Medical Device Definition
The Court of Justice of the European Union has issued a preliminary ruling in Case C-427/24 Diagramm Halbach, establishing critical principles for determining whether products qualify as medical devices under the EU Medical Device Regulation. The judgment clarifies that manufacturer advertising alone does not determine medical device status, and that products must objectively perform medical purposes to fall within the regulatory definition.
Worldwide Consumer
AP
Arnold & Porter
Article
Regulatory Pulse - July 2026
The Federal Government has launched the National Guidelines for Public Procurement of Food and Related Services, positioning government procurement as a public-health intervention to promote healthier diets, improved nutrition and prevention of non-communicable diseases. The Guidelines are intended to influence food served and purchased across public institutions, including hospitals, schools and government establishments
Nigeria Healthcare
HE
Health Ethics and Law Consulting
Article
The EU Data Act’s Access-by-Design Deadline: What Life Sciences Companies Need To Know Before September 2026
The EU Data Act's September 2026 deadline introduces a new access-by-design requirement for connected medical devices and related services, but the practical impact may be more limited than manufacturers expect. This analysis examines what life sciences companies must do to comply with both the upcoming milestone and the broader set of obligations that have been in force since September 2025.
European Union Privacy
AP
Arnold & Porter
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Regulatory Pulse - July 2026
The Federal Government has launched the National Guidelines for Public Procurement of Food and Related Services, positioning government procurement as a public-health intervention to promote healthier diets, improved nutrition and prevention of non-communicable diseases. The Guidelines are intended to influence food served and purchased across public institutions, including hospitals, schools and government establishments
Nigeria Healthcare
HE
Health Ethics and Law Consulting
Article
Council Of The EU Agrees On Mandate On Measures To Advance Biotechnology Innovation In The EU
The European Council has adopted a position on targeted amendments to health legislation aimed at streamlining regulations for genetically modified microorganisms and updating organ processing rules to reflect scientific advances. The proposed changes seek to create a more efficient regulatory process for certain GMMs meeting predetermined safety standards while enabling innovative approaches to organ transplantation that could extend the time between procurement and transplant.
European Union Healthcare
BC
Bergeson & Campbell
See more

Food and Drugs Law

Article
Updates On The Recent Activities And Other Developments In National Agency For Food And Drug Administration & Control (NAFDAC)
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning over a suspected counterfeit version of the asthma medication Pulmicort® (Budesonide), detected in the Nigerian market and marketed under the name “Ulmicort 0.5mg/ml Inhalation Suspension”. In Public Alert No. 037/2026, the Agency cautioned that the suspected fake medicine may lack the correct ingredient or contain harmful substances and urged healthcare professionals and the public to report any suspected counterfeit medicines to the nearest NAFDAC office.
Nigeria Healthcare
SA
S.P.A. Ajibade & Co.
Article
Regulatory Pulse - July 2026
The Federal Government has launched the National Guidelines for Public Procurement of Food and Related Services, positioning government procurement as a public-health intervention to promote healthier diets, improved nutrition and prevention of non-communicable diseases. The Guidelines are intended to influence food served and purchased across public institutions, including hospitals, schools and government establishments
Nigeria Healthcare
HE
Health Ethics and Law Consulting
Article
Health And Pharmaceutical Sector Round-Up For Q2 Of 2026: Key Developments And Outlook For Q3 2026
Q2 2026 marked a pivotal period for Nigeria's health and pharmaceutical sector, as the government shifted from broad policy statements to concrete implementation measures. What do the new National Malaria Strategic Plan, emergency medical response initiatives, and digital pharmacy regulations mean for healthcare operators, investors, and service providers navigating this evolving regulatory landscape?
Nigeria Healthcare
SB
Stren & Blan Partners
See more

Latest Videos

See more